BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22227230)

  • 1. Early detection and visualization of human adenovirus serotype 5-viral vectors carrying foot-and-mouth disease virus or luciferase transgenes in cell lines and bovine tissues.
    Montiel N; Smoliga G; Arzt J
    Vaccine; 2012 Feb; 30(9):1690-701. PubMed ID: 22227230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent biodistribution and transgene expression of a recombinant human adenovirus serotype 5-luciferase vector as a surrogate for rAd5-FMDV vaccines in cattle.
    Montiel NA; Smoliga G; Arzt J
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):37-48. PubMed ID: 23219159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
    Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
    Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
    Pena L; Moraes MP; Koster M; Burrage T; Pacheco JM; Segundo FD; Grubman MJ
    Vaccine; 2008 Oct; 26(45):5689-99. PubMed ID: 18762225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine.
    Pacheco JM; Brum MC; Moraes MP; Golde WT; Grubman MJ
    Virology; 2005 Jul; 337(2):205-9. PubMed ID: 15893355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
    Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering better vaccines for foot-and-mouth disease.
    Mason PW; Chinsangaram J; Moraes MP; Mayr GA; Grubman MJ
    Dev Biol (Basel); 2003; 114():79-88. PubMed ID: 14677679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.
    Chen W; Liu M; Jiao Y; Yan W; Wei X; Chen J; Fei L; Liu Y; Zuo X; Yang F; Lu Y; Zheng Z
    J Virol; 2006 Apr; 80(7):3559-66. PubMed ID: 16537624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine.
    Wu Q; Moraes MP; Grubman MJ
    Virus Res; 2003 Jun; 93(2):211-9. PubMed ID: 12782369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.
    Moraes MP; Mayr GA; Mason PW; Grubman MJ
    Vaccine; 2002 Feb; 20(11-12):1631-9. PubMed ID: 11858872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle.
    Barrera J; Brake DA; Kamicker BJ; Purcell C; Kaptur R; Schieber T; Lechtenberg K; Miller TD; Ettyreddy D; Brough DE; Butman BT; Colby M; Neilan JG
    Transbound Emerg Dis; 2018 Apr; 65(2):447-455. PubMed ID: 29076657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus.
    Dias CC; Moraes MP; Segundo FD; de los Santos T; Grubman MJ
    J Interferon Cytokine Res; 2011 Feb; 31(2):227-36. PubMed ID: 20874428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
    Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
    Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model.
    Neilan JG; Schutta C; Barrera J; Pisano M; Zsak L; Hartwig E; Rasmussen MV; Kamicker BJ; Ettyreddy D; Brough DE; Butman BT; Brake DA
    BMC Vet Res; 2018 Aug; 14(1):254. PubMed ID: 30157853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.